Last reviewed · How we verify
Mem-Lok collagenous membrane
Mem-Lok collagenous membrane is a Biologic drug developed by University of Kentucky. It is currently in Phase 1 development. Also known as: Mem-Lok.
At a glance
| Generic name | Mem-Lok collagenous membrane |
|---|---|
| Also known as | Mem-Lok |
| Sponsor | University of Kentucky |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mem-Lok collagenous membrane CI brief — competitive landscape report
- Mem-Lok collagenous membrane updates RSS · CI watch RSS
- University of Kentucky portfolio CI
Frequently asked questions about Mem-Lok collagenous membrane
What is Mem-Lok collagenous membrane?
Mem-Lok collagenous membrane is a Biologic drug developed by University of Kentucky.
Who makes Mem-Lok collagenous membrane?
Mem-Lok collagenous membrane is developed by University of Kentucky (see full University of Kentucky pipeline at /company/university-of-kentucky).
Is Mem-Lok collagenous membrane also known as anything else?
Mem-Lok collagenous membrane is also known as Mem-Lok.
What development phase is Mem-Lok collagenous membrane in?
Mem-Lok collagenous membrane is in Phase 1.
Related
- Manufacturer: University of Kentucky — full pipeline
- Also known as: Mem-Lok
- Compare: Mem-Lok collagenous membrane vs similar drugs
- Pricing: Mem-Lok collagenous membrane cost, discount & access